Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100


Radiofrequency ablation of lung cancer at Okayama University Hospital: a review of 10 years of experience.

Hiraki T, Gobara H, Mimura H, Toyooka S, Fujiwara H, Yasui K, Sano Y, Iguchi T, Sakurai J, Tajiri N, Mukai T, Matsui Y, Kanazawa S.

Acta Med Okayama. 2011 Oct;65(5):287-97.


Pulmonary radiofrequency ablation: long-term safety and efficacy in 153 patients.

Simon CJ, Dupuy DE, DiPetrillo TA, Safran HP, Grieco CA, Ng T, Mayo-Smith WW.

Radiology. 2007 Apr;243(1):268-75.


Radiofrequency ablation for the treatment of stage I non-small cell lung cancer in high-risk patients.

Pennathur A, Luketich JD, Abbas G, Chen M, Fernando HC, Gooding WE, Schuchert MJ, Gilbert S, Christie NA, Landreneau RJ.

J Thorac Cardiovasc Surg. 2007 Oct;134(4):857-64. Epub 2007 Aug 29.


Radiofrequency ablation as treatment for pulmonary metastasis of colorectal cancer.

Hiraki T, Gobara H, Iguchi T, Fujiwara H, Matsui Y, Kanazawa S.

World J Gastroenterol. 2014 Jan 28;20(4):988-96. doi: 10.3748/wjg.v20.i4.988. Review.


Radiofrequency ablation for the treatment of non-small cell lung cancer in marginal surgical candidates.

Fernando HC, De Hoyos A, Landreneau RJ, Gilbert S, Gooding WE, Buenaventura PO, Christie NA, Belani C, Luketich JD.

J Thorac Cardiovasc Surg. 2005 Mar;129(3):639-44.


A case of delayed massive hemothorax caused by the rupture of a pulmonary artery pseudoaneurysm after radiofrequency ablation of lung tumors.

Soh J, Toyooka S, Gobara H, Hiraki T, Sugimoto S, Yamane M, Oto T, Kanazawa S, Miyoshi S.

Jpn J Clin Oncol. 2012 Jul;42(7):646-9. doi: 10.1093/jjco/hys068. Epub 2012 May 11.


Primary non-small cell lung cancer: review of frequency, location, and time of recurrence after radiofrequency ablation.

Beland MD, Wasser EJ, Mayo-Smith WW, Dupuy DE.

Radiology. 2010 Jan;254(1):301-7. doi: 10.1148/radiol.2541090174.


Radiofrequency ablation of lung malignancies.

Nguyen CL, Scott WJ, Goldberg M.

Ann Thorac Surg. 2006 Jul;82(1):365-71. Review.


Response to radiofrequency ablation of pulmonary tumours: a prospective, intention-to-treat, multicentre clinical trial (the RAPTURE study).

Lencioni R, Crocetti L, Cioni R, Suh R, Glenn D, Regge D, Helmberger T, Gillams AR, Frilling A, Ambrogi M, Bartolozzi C, Mussi A.

Lancet Oncol. 2008 Jul;9(7):621-8. doi: 10.1016/S1470-2045(08)70155-4. Epub 2008 Jun 17.


Radiofrequency ablation for lung tumors: outcomes, effects on survival, and prognostic factors.

Akhan O, Güler E, Akıncı D, Çiftçi T, Köse IÇ.

Diagn Interv Radiol. 2016 Jan-Feb;22(1):65-71. doi: 10.5152/dir.2015.14378.


Radiofrequency ablation in lung cancer: promising results in safety and efficacy.

Suh R, Reckamp K, Zeidler M, Cameron R.

Oncology (Williston Park). 2005 Oct;19(11 Suppl 4):12-21. Review.


Radiofrequency ablation of T1 lung carcinoma: comparison of outcomes for first primary, metachronous, and synchronous lung tumors.

Ridge CA, Silk M, Petre EN, Erinjeri JP, Alago W, Downey RJ, Sofocleous CT, Thornton RH, Solomon SB.

J Vasc Interv Radiol. 2014 Jul;25(7):989-96. doi: 10.1016/j.jvir.2014.02.021. Epub 2014 Apr 2.


Is radiofrequency ablation more effective than stereotactic ablative radiotherapy in patients with early stage medically inoperable non-small cell lung cancer?

Bilal H, Mahmood S, Rajashanker B, Shah R.

Interact Cardiovasc Thorac Surg. 2012 Aug;15(2):258-65. doi: 10.1093/icvts/ivs179. Epub 2012 May 10. Review.


A novel strategy for treatment of metastatic pulmonary tumors: radiofrequency ablation in conjunction with surgery.

Sano Y, Kanazawa S, Mimura H, Gobara H, Hiraki T, Fujiwara H, Yamane M, Toyooka S, Oto T, Date H.

J Thorac Oncol. 2008 Mar;3(3):283-8. doi: 10.1097/JTO.0b013e3181645443.


Repeat radiofrequency ablation for local progression of lung tumors: does it have a role in local tumor control?

Hiraki T, Mimura H, Gobara H, Sano Y, Fujiwara H, Date H, Kanazawa S.

J Vasc Interv Radiol. 2008 May;19(5):706-11. doi: 10.1016/j.jvir.2007.12.441. Epub 2008 Mar 17.


Determinants of local progression after computed tomography-guided percutaneous radiofrequency ablation for unresectable lung tumors: 9-year experience in a single institution.

Okuma T, Matsuoka T, Yamamoto A, Oyama Y, Hamamoto S, Toyoshima M, Nakamura K, Miki Y.

Cardiovasc Intervent Radiol. 2010 Aug;33(4):787-93. doi: 10.1007/s00270-009-9770-9. Epub 2009 Dec 5.


Radiofrequency ablation for treatment of medically inoperable stage I non-small cell lung cancer.

Lanuti M, Sharma A, Digumarthy SR, Wright CD, Donahue DM, Wain JC, Mathisen DJ, Shepard JA.

J Thorac Cardiovasc Surg. 2009 Jan;137(1):160-6. doi: 10.1016/j.jtcvs.2008.08.034. Epub 2008 Oct 30.


Radiofrequency ablation for the treatment of lung neoplasm.

Pennathur A, Abbas G, Schuchert M, Landreneau RJ, Luketich JD.

Expert Rev Med Devices. 2008 Sep;5(5):613-21. doi: 10.1586/17434440.5.5.613. Review.


Radiofrequency ablation is a valid treatment option for lung metastases: experience in 566 patients with 1037 metastases.

de Baère T, Aupérin A, Deschamps F, Chevallier P, Gaubert Y, Boige V, Fonck M, Escudier B, Palussiére J.

Ann Oncol. 2015 May;26(5):987-91. doi: 10.1093/annonc/mdv037. Epub 2015 Feb 16.


Percutaneous image-guided thermal ablation and radiation therapy: outcomes of combined treatment for 41 patients with inoperable stage I/II non-small-cell lung cancer.

Grieco CA, Simon CJ, Mayo-Smith WW, DiPetrillo TA, Ready NE, Dupuy DE.

J Vasc Interv Radiol. 2006 Jul;17(7):1117-24.


Supplemental Content

Support Center